WW International Inc. (WW)
NASDAQ (NGS) NASDAQ (NGS) Primary 
WW International, Inc. (WW) Q1 2026 Earnings Call Transcript
WW International, Inc. (WW) Q1 2026 Earnings Call Transcript
WW International Q1 Earnings Call Highlights
WW International NASDAQ: WW, operator of WeightWatchers, reaffirmed its 2026 financial outlook after reporting first-quarter results that reflected continued pressure in its legacy behavioral subscription business, offset in part by growth in its clinical weight-management offering and higher-value membership tiers.
WW International Logs Lower Sales
WW International posted lower revenue in the first quarter, as behavioral subscription sales fell.
WW International: First Normal Quarter Shows Signs Of Stability
WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cautious Q4 guidance, which may keep investors wary until trends improve. Key catalysts ahead include FDA decisions on GLP-1 compounding, expanded insurance coverage, and new partnerships with pharma and insurance providers.
WeightWatchers to offer faster delivery of weight loss drugs through new partnership with Amazon Pharmacy
Weight management company WW International, also known as WeightWatchers (NASDAQ:WW), has partnered with Amazon Pharmacy to streamline access to weight management medications for WeightWatchers Clinic members. Under the partnership, members can view real-time medication availability, compare delivery options, and receive prescriptions through Amazon Pharmacy.
WW International, Inc. (WW) Q2 2025 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW ) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants David Helderman - Director of Investor Relations Felicia DellaFortuna - Chief Financial Officer Jon Volkmann - Chief Operations Officer Tara M. Comonte - President, CEO & Director Conference Call Participants Alex Joseph Fuhrman - Lucid Capital Markets, LLC, Research Division Nathaniel Jay Feather - Morgan Stanley, Research Division Operator Good day, and welcome to the WeightWatchers Second Quarter 2025 Earnings Conference Call.
WeightWatchers reboots with focus on medical weight-loss and menopause care
Weight Watchers International (NASDAQ:WW) has emerged from bankruptcy with a renewed strategy, aiming to combine medical weight-loss treatments with long-term lifestyle support. The company cleared over $1.15 billion of debt, more than 70% of its total, through a US court restructuring process, strengthening its financial position.
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the fate of WeightWatchers, which declared bankruptcy this week, citing vastly increased use of the new blockbuster medicines.
WW International stock tumbles as WeightWatchers files for Chapter 11 bankruptcy protection
WeightWatchers said Tuesday it is filing for Chapter 11 bankruptcy protection to eliminate $1.15 billion in debt and focus on its transition into a telehealth services provider.Parent WW International Inc. said it has the support of nearly three-quarters of its debt holders. It expects to emerge from bankruptcy within 45 days, if not sooner.WeightWatchers, which was founded more than 60 years ago, has struggled recently.
Weight Watchers shares shed 43% of value as Chapter 11 bankruptcy deal struck
Weight Watchers International (NASDAQ:WW) shares plunged 43% to $0.45 as it struck a deal for a "pre-packaged" Chapter 11 bankruptcy, aiming to clear $1.15 billion of debt off its balance sheet. The company, officially known as WW International, has cut a deal with a group of lenders and bondholders holding around 72% of its debt, with the process expected to zip through the courts in around 45 days.
WW International (WW) Reports Q1 Loss, Lags Revenue Estimates
WW International (WW) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.06 per share a year ago.
WeightWatchers Files Bankruptcy to Adapt to Chemically Induced Weight-Loss Future
The icon of a bygone dieting era seeks to shed debt and restructure as women gravitate toward drugs to lose weight.
